Skip to main content

Shoujie Shan, MD

Original Contribution
08/01/2008
Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...
Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...
Sirolimus-eluting and...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Bifurcation lesions are still technically challenging, even in the era of modern drug-eluting stents (DES).1 Data on bare-metal stenting (BMS) did not demonstrate any advantages of the double-stent technique over single stenting because of a...
Bifurcation lesions are still technically challenging, even in the era of modern drug-eluting stents (DES).1 Data on bare-metal stenting (BMS) did not demonstrate any advantages of the double-stent technique over single stenting because of a...
Bifurcation lesions are still...
08/01/2008
Journal of Invasive Cardiology